{"id":9664,"date":"2024-04-03T00:00:00","date_gmt":"2024-04-03T03:00:00","guid":{"rendered":"https:\/\/dragpharma.cl\/producto\/fatroximin\/"},"modified":"2024-10-07T11:57:35","modified_gmt":"2024-10-07T14:57:35","slug":"fatroximin","status":"publish","type":"product","link":"https:\/\/dragpharma.cl\/en\/producto\/fatroximin\/","title":{"rendered":"Fatroximin\u00ae"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

FATROXIMIN,\u00ae<\/strong> an intramammary ointment, is indicated in cow drying for the therapy of existing subclinical mastitis, the prevention of possible infection during the dry period, and the prevention of acute postpartum mastitis, produced by Gram-positive (Streptococcus spp., Staphylococcus spp., Corynebacterium spp.)<\/em> and Gram-negative (E. coli<\/em>) microorganisms.
\nIt acts on the most common udder microbial species sensitive to Rifaximin, such as: Streptococcus agalatiae, Streptococcus dysgalactiae, Streptococcus uberis, Streptococcus faecalis, Staphylococcus aureus<\/em> (including penicillin-resistant strains) and Staphylococcus epidermidis<\/em>….<\/p>\n

Read more<\/a><\/i><\/span><\/span><\/p>\n","protected":false},"featured_media":19848,"template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[1761],"product_tag":[2628,2625,2630,1965,1962,2629,2627],"especies":[1740],"therapeutic_action":[1762],"class_list":{"0":"post-9664","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-cat-antimicrobials","7":"product_tag-doorknob","8":"product_tag-drying-en","9":"product_tag-fatroximin-en","10":"product_tag-mastitis-en","11":"product_tag-of","12":"product_tag-tearpia-en","13":"product_tag-ubrisec-en","14":"especies-bovines","15":"therapeutic_action-antimicrobials","17":"first","18":"instock","19":"product-type-simple"},"acf":{"id_favoritos":"1135","segundo_titulo":"Antimicrobials","efecto_medico":" Antibiotic for Drying Therapy","archivos_n":null,"ficha_tecnica":[{"titulo":"Dosage form","tipo_de_contenido":"contenido","contenido":"Intramammary ointment.","tabla":null},{"titulo":"Therapeutic action","tipo_de_contenido":"contenido","contenido":"Antibiotic for Drying Therapy","tabla":null},{"titulo":"Composition","tipo_de_contenido":"contenido","contenido":"Each 5 mL syringe tube contains:
\nRifaximin............................... 0.100 g
\nExcipients c.s.p................. 5 mL
","tabla":null},{"titulo":"Indications for use","tipo_de_contenido":"contenido","contenido":"FATROXIMIN,\u00ae<\/strong> an intramammary ointment, is indicated in cow drying for the therapy of existing subclinical mastitis, the prevention of possible infection during the dry period and the prevention of acute postpartum mastitis, produced by Gram-positive ( Streptococcus spp., Staphylococcus spp., Corynebacterium spp.) and Gram-negative (E. coli) microorganisms.<\/em>\nIt acts on the most common udder microbial species sensitive to Rifaximin, such as: Streptococcus agalatiae, Streptococcus dysgalactiae, Streptococcus uberis, Streptococcus faecalis, Staphylococcus aureus<\/em> (including penicillin-resistant strains) and Staphylococcus epidermidis.<\/em>","tabla":null},{"titulo":"Target Species","tipo_de_contenido":"contenido","contenido":"Cattle: cows in the drying period.","tabla":null},{"titulo":"Dosage and directions for use","tipo_de_contenido":"contenido","contenido":"Administer one 5 mL syringe tube of FATROXIMIN\u00ae<\/strong>, intramammary ointment, (equivalent to 100 mg of Rifaximin) per quarter of the breast, after the last milking, prior to drying.\nMilk the room thoroughly and after disinfection of the nipple hole, then apply FATROXIMIN\u00ae<\/strong>, intramammary ointment, inserting the cannula and injecting the entire contents of the syringe.\nAfterwards, the nipple should be massaged from bottom to top to diffuse the product throughout the room.","tabla":null},{"titulo":"Characteristics of the active substance","tipo_de_contenido":"contenido","contenido":"FATROXIMIN\u00ae<\/strong>, intramammary ointment is a preparation based on Rifaximin, a new antibiotic obtained by original synthesis, belonging to the Rifamycin family. The particular chemical structure has given the molecule chemical-physical characteristics such that it has a pharmacokinetics that are completely different from the other rifamycins currently on the market. The studies carried out reveal a practically non-existent passage through the intramammary epithelium, allowing an optimal availability of Rifaximin at the level of the fourth treated.\nFATROXIMIN\u00ae<\/strong>, intramammary ointment, has a high bactericidal antibacterial activity against Gram-positive (Streptococcus spp., Staphylococcus spp., Corynebacterium spp.)<\/em> and Gram-negative (E. coli<\/em>) microorganisms.\nIt acts on the most common microbial species in the udder.","tabla":null},{"titulo":"Characteristics of the syringe","tipo_de_contenido":"contenido","contenido":"FATROXIMIN\u00ae<\/strong>, intramammary ointment has intramammary syringes with the \"Twinsert\" system.\nThe \"Twinsert\" system allows a partial and also a complete insertion of the antimastitic syringe cannula into the nipple canal according to the operator's requirements.\nRecent studies show that antimastitic treatment through a partial insertion of the cannula into the nipple canal significantly reduces the flare-up of\nnew breast infections.\nIn fact, the complete insertion of the cannulas dilates the nipple sphincter making it easier for bacteria to enter, and at the same time, it can transport the bacteria present\nin the keratin layer, lining the nipple orifice, directly to the nipple cistern.","tabla":null},{"titulo":"Vehicle Features","tipo_de_contenido":"contenido","contenido":"FATROXIMIN\u00ae<\/strong>, intramammary ointment, is prepared in such a way that it has a high stability and a constant viscosity to the variation of temperature\nenvironmental.\nFATROXIMIN\u00ae<\/strong>, ointment for intramammary drying is perfectly tolerated, does not irritate the udder or produce any type of reactions. The presence of the vehicle results in an immediate and complete distribution of the active ingredient.\nFATROXIMIN\u00ae<\/strong>, a properly applied intramammary ointment, remains on the udder throughout the drying period and is eliminated in the colostrum, so that the milk from the first milking does not contain residues of the antibiotic.","tabla":null},{"titulo":"Clinical efficacy","tipo_de_contenido":"contenido","contenido":"Field tests have shown:\n